India becoming an attractive option for global pharmaceutical supply chain: Report
- Posted on February 20, 2025
- By Financial Express
- 6 Views
India becoming an attractive option for global pharmaceutical supply chain: Report
India’s CRDMO industry is set to grow significantly, reaching USD 14 billion by 2028 with a 14% CAGR due to pharmaceutical outsourcing and regulatory support. The US Biosecure Act could boost growth even further, potentially reaching USD 22 billion by 2030.
